This document provides guidance on interpreting abnormal liver function tests (LFTs). It notes that 2.5% of the population has raised LFTs and normal tests do not rule out liver disease. A careful history should be taken regarding risk factors like drugs, alcohol, medical history. Physical exam can reveal signs of liver disease. The likely diagnosis should be pursued rather than following an algorithm. Mild abnormalities with no risk factors may warrant repeating tests after lifestyle changes. Key LFTs markers and indications are described for hepatocellular damage, cholestasis and liver synthetic function. Acute hepatitis causes are outlined. Investigation approach is provided depending on severity of ALT/AST elevations. Liver biopsy can accurately grade disease severity
This document provides guidance on interpreting abnormal liver function tests (LFTs). It notes that 2.5% of the population has raised LFTs and normal tests do not rule out liver disease. A careful history should be taken regarding risk factors like drugs, alcohol, medical history. Physical exam can reveal signs of liver disease. The likely diagnosis should be pursued rather than following an algorithm. Mild abnormalities with no risk factors may warrant repeating tests after lifestyle changes. Key LFTs markers and indications are described for hepatocellular damage, cholestasis and liver synthetic function. Acute hepatitis causes are outlined. Investigation approach is provided depending on severity of ALT/AST elevations. Liver biopsy can accurately grade disease severity
This document provides guidance on interpreting abnormal liver function tests (LFTs). It notes that 2.5% of the population has raised LFTs and normal tests do not rule out liver disease. A careful history should be taken regarding risk factors like drugs, alcohol, medical history. Physical exam can reveal signs of liver disease. The likely diagnosis should be pursued rather than following an algorithm. Mild abnormalities with no risk factors may warrant repeating tests after lifestyle changes. Key LFTs markers and indications are described for hepatocellular damage, cholestasis and liver synthetic function. Acute hepatitis causes are outlined. Investigation approach is provided depending on severity of ALT/AST elevations. Liver biopsy can accurately grade disease severity
This document provides guidance on interpreting abnormal liver function tests (LFTs). It notes that 2.5% of the population has raised LFTs and normal tests do not rule out liver disease. A careful history should be taken regarding risk factors like drugs, alcohol, medical history. Physical exam can reveal signs of liver disease. The likely diagnosis should be pursued rather than following an algorithm. Mild abnormalities with no risk factors may warrant repeating tests after lifestyle changes. Key LFTs markers and indications are described for hepatocellular damage, cholestasis and liver synthetic function. Acute hepatitis causes are outlined. Investigation approach is provided depending on severity of ALT/AST elevations. Liver biopsy can accurately grade disease severity
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 22
INTERPRETATION
OF ABNORMAL LFTS DR ALEX MOGERE CONSULTANT PHYSICIAN Principles of invx of abn LFTs
• 2.5 of population have raised LFTs
• Normal LFTs do not exclude liver disease • Interpret LFTs in clinical context • Take a careful history for risk factors, drugs (inc OTCs), alcohol, comorbidity, autoimmunity • Physical examination for liver disease • Chase likely diagnosis rather than follow algorithm unless there are no clues • If mild abnormalities and no risk factors or suggestion of serious liver disease , repeat LFTs after an interval (with lifestyle modification) LFTS • LFTsMarkers of hepatocellular damage • Cholestasis • Liver synthetic function Markers of hepatocellular damage • AST- liver, heart skeletal muscle, kidneys, brain, RBCs • In liver 20 %activity is cytosolic and 80 % mitochondrial • Clearance performed by sinusoidal cells, half-life 17hrs • ALT more specific to liver, v.low concentrations in kidney and skeletal muscles. • Half-life 47hrs GGT • Gamma-GT hepatocytes and biliary epithelial cells, pancreas, renal tubules and intestine • Very sensitive but Non-specific • Raised in ANY liver disease hepatocellular or cholestatic • Usefulness limited • Confirm hepatic source for a raised ALP • Alcohol • Isolated increase does not require any further evaluation, suggest watch and rpt 3/12 only if other LFTs become abnormal then investigate CHOLESTASIS • ALP liver and bone (placenta, kidneys, intestines or WCC) • Hepatic ALP present on surface of bile duct epithelia and accumulating bile salts increase its release from cell surface. Takes time for induction of enzyme levels so may not be first enzyme to rise and half-life is 1 week. • ALP isoenzymes, 5-NT or gamma GT may be necessary to evaluate the origin of ALP Cont. cholestasis •Isolated ALP 3rd trimester, adolescents •Bone exclude by raised GGT, 5-NT or isoenzymes •May suggest biliary obstruction, chronic liver disease or hepatic mass/tumour •Liver USS/CT most important investigation-dilated ducts •Ca pancreas, CBD stones, cholangioca or liver mets Cont . Cholestasis(non-dilated ducts) • Cholestatic jaundice Drugs- Antibiotics, Nsaids, Hormones, ACEI • PBC anti- mitochondrial Ab, M2 fraction, IgM • PSC associated with IBD 70, p-ANCA, MRCP and liver biopsy • Chronic liver disease • Cholangiocarcinoma beware fluctuating levels • Primary or Metastatic cancer, lymphoma • Infiltrative sarcoid, inflammatory-PMR, IBD • Liver biopsy often required Bilirubin, albumin and PTI(INR) • Useful indicators of liver synthetic function • In primary care when associated with liver disease abnormalities should raise concern • Thrombocytopenia is a sensitive indicator of liver fibrosis • Unconjugated bilirubin is raised in Haemolysis,Gilbert’s syndrome, a benign, inherited disease Acute hepatitis • Viral Hep A, B, C, E, CMV, EBV • ALT levels usually peak before jaundice appears. • Jaundice occurs in 70% Hep A, 35% acute Hep B, 25% Hep C • Check for exposure • Check Hep A IgM, Hep B core IgM and HepBsAg, Hep C IgG or Hep C RNA Investigation of Abnormal LFTs - ALT/AST 2-5x normal (100-200)
• History and Examination
• Discontinue hepatotoxic drugs • Continue statins but monitor LFTs monthly • Lifestyle modification (lose wt, reduce alcohol, diabetic control) • Repeat LFTs at 1 month and 6 months Cont.Investigation of Abnormal LFTs - ALT/AST 2-5x normal (100-200)
• If still abnormal at 6 months
• Consider referral to secondary care • Hepatitis serology (B, C) • Iron studies: transferrin saturation .ferritin • Autoantibodies immunoglobulins • Consider caeruloplasmin • Alpha-1- antitrypsin • Coeliac serology • TFTs, lipids/glucose • Consider liver biopsy esp if ALT gt 100) Value of liver biopsy in deranged LFT • The most accurate way to grade the severity of liver disease • Aminotransferase levels correlate poorly with histological activity • Narrows the diagnostic options, if not diagnostic THANK YOU!